<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30158853</article-id>
<article-id pub-id-type="pmc">6104450</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00246</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Long-Term Isolation Elicits Depression and Anxiety-Related Behaviors by Reducing Oxytocin-Induced GABAergic Transmission in Central Amygdala</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Rafael T.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/565432/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Young-Beom</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/536872/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Eui-Ho</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/565477/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jin Yong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/575015/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ryu</surname>
<given-names>Changhyeon</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hye Y.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>JaeHee</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pahk</surname>
<given-names>Kisoo</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shanyu</surname>
<given-names>Cui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/204378/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Back</surname>
<given-names>Seung K.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hee J.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Yang In</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/580355/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Na</surname>
<given-names>Heung S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Neuroscience Research Institute and Department of Physiology, Korea University College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Anatomy, Korea University College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff3"><sup>3</sup><institution>Neuroscience Research Institute and Department of Physiology, College of Medicine, Seoul National University</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Neuroscience, Korea University College of Medicine</institution>, <addr-line>Seoul</addr-line>, <country>South Korea</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Pharmaceutics and Biotechnology, College of Medical Engineering, Konyang University</institution>, <addr-line>Chungnam</addr-line>, <country>South Korea</country></aff>
<aff id="aff6"><sup>6</sup><institution>Division of Biological Science and Technology, Science and Technology College, Yonsei University</institution>, <addr-line>Wonju</addr-line>, <country>South Korea</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Rolf Sprengel, Max-Planck-Institut für medizinische Forschung, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Valery Grinevich, Deutsches Krebsforschungszentrum, Helmholtz-Gemeinschaft Deutscher Forschungszentren (HZ), Germany; Alexandre Charlet, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<corresp id="c001">*Correspondence: Heung S. Na, <email>hsna@korea.ac.kr</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>These authors have contributed equally to this work.</p>
</fn>
<fn fn-type="other" id="fn003">
<p>This article was submitted to , a section of the journal Frontiers in Molecular Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>246</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>6</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Han, Kim, Park, Kim, Ryu, Kim, Lee, Pahk, Shanyu, Kim, Back, Kim, Kim and Na.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Han, Kim, Park, Kim, Ryu, Kim, Lee, Pahk, Shanyu, Kim, Back, Kim, Kim and Na</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Isolation stress is a major risk factor for neuropsychiatric disorders such as depressive and anxiety disorders. However, the molecular mechanisms underlying isolation-induced neuropsychiatric disorders remain elusive. In the present study, we investigated the subcellular mechanisms by which long-term isolation elicits depression and anxiety-related behaviors in mice. First, we found that long-term isolation induced depression-related behaviors in the forced swimming test (FST) and the sucrose preference test, as well as anxiety-related behaviors in the elevated zero maze test (EZMT) and the open field test. Next, we showed that intracentral amygdala (CeA) injection of oxytocin (OXT), but not intracerebroventricular injection, attenuated isolation-induced depression and anxiety-related behaviors via oxytocin receptor (OXTR), not vasopressin-1a receptor (V1aR), in the FST and EZMT, respectively. Quantitative real-time polymerase chain reaction analysis revealed that after 5 weeks of isolation, mRNA transcription of OXTR in the CeA, but not that of V1aR, significantly decreased, whereas OXT and vasopressin mRNA transcription in the paraventricular nucleus of hypothalamus did not change significantly. Whole-cell patch clamping of acute brain slices demonstrated that the frequency of miniature inhibitory postsynaptic currents (mIPSCs) in CeA neurons, but not their amplitude, was lower in isolated mice than in group-housed mice. Notably, OXT treatment increased the mIPSC frequency in the CeA neurons, but to a lesser extent in the case of isolated mice than in that of group-housed mice via OXTR. Taken together, our findings suggest that long-term isolation down-regulates OXTR mRNA transcription and diminishes OXT-induced inhibitory synaptic transmission in the CeA and may contribute to the development of depression and anxiety-related behaviors in isolated mice through the enhancement of CeA activity.</p>
</abstract>
<kwd-group>
<kwd>oxytocin</kwd>
<kwd>inhibitory synaptic transmission</kwd>
<kwd>central amygdala (CeA)</kwd>
<kwd>gamma-aminobutyric acid</kwd>
<kwd>isolation</kwd>
<kwd>depression and anxiety disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Korea University<named-content content-type="fundref-id">10.13039/501100002642</named-content></funding-source>
<award-id rid="cn001">K1721361</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="55"></ref-count>
<page-count count="12"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Depressive and anxiety disorders are among the most prevalent neuropsychiatric disorders (<xref ref-type="bibr" rid="B11">Fava et al., 2000</xref>). Despite their distinct difference in symptoms, both disorders frequently coexist in one patient (<xref ref-type="bibr" rid="B3">Ballenger, 1999</xref>; <xref ref-type="bibr" rid="B20">Ionescu et al., 2013</xref>) and share common pathophysiology and risk factors, including abnormal activity in the amygdala and social stressors, respectively (<xref ref-type="bibr" rid="B10">England and Sim, 2009</xref>; <xref ref-type="bibr" rid="B13">Grav et al., 2012</xref>; <xref ref-type="bibr" rid="B49">Wang et al., 2014</xref>). For example, hyperactivity in the amygdala has not only been characterized in anxiety disorder but is also implicated in depressive disorder (<xref ref-type="bibr" rid="B43">Shin and Liberzon, 2010</xref>; <xref ref-type="bibr" rid="B50">Yang et al., 2010</xref>). Abnormal processing of emotion and aberrant neural circuitry of the amygdala were implicated in patients with depressive disorder and the animal model of depression (<xref ref-type="bibr" rid="B42">Sheline et al., 2001</xref>; <xref ref-type="bibr" rid="B39">Roberson-Nay et al., 2006</xref>; <xref ref-type="bibr" rid="B31">Mottolese et al., 2014</xref>). In addition to the dysregulated activity of the amygdala, social stress is also a common risk factor of depressive and anxiety disorders. Social support was reported to moderate the effects of stress on depressive disorder. Conversely, social isolation is a major risk factor for depressive and anxiety disorders (<xref ref-type="bibr" rid="B49">Wang et al., 2014</xref>).</p>
<p>Oxytocin (OXT) is a neurohormone synthesized in the hypothalamus. OXT-expressing neurons project directly to other brain areas such as the amygdala (<xref ref-type="bibr" rid="B18">Huber et al., 2005</xref>; <xref ref-type="bibr" rid="B25">Knobloch et al., 2012</xref>; <xref ref-type="bibr" rid="B5">Boccia et al., 2013</xref>). OXT has attracted attention for its role in mediating social stress and modulating the activity of the amygdala (<xref ref-type="bibr" rid="B18">Huber et al., 2005</xref>; <xref ref-type="bibr" rid="B48">Viviani et al., 2011</xref>; <xref ref-type="bibr" rid="B35">Olff et al., 2013</xref>). OXT was reported to mediate isolation-induced behavioral changes and elevate social interactions in experimental animals and human studies (<xref ref-type="bibr" rid="B16">Han et al., 2016b</xref>; <xref ref-type="bibr" rid="B51">Yatawara et al., 2016</xref>). In addition, recent studies have implicated the potential roles of OXT in anxiolysis and shown therapeutic benefits of OXT for subsets of patients with depressive disorders (<xref ref-type="bibr" rid="B45">Slattery and Neumann, 2010b</xref>). Furthermore, oxytocinergic circuits from the hypothalamus to the amygdala have been shown to modulate fear responses (<xref ref-type="bibr" rid="B1">Altemus et al., 2001</xref>; <xref ref-type="bibr" rid="B48">Viviani et al., 2011</xref>; <xref ref-type="bibr" rid="B25">Knobloch et al., 2012</xref>). However, in spite of the close correlation between OXT as a mediator of social stress and neuropsychiatric disorders such as depressive and anxiety disorders, the neural mechanisms underlying the effects of social stress on the oxytocinergic circuits and the hyperactivity in the amygdala with regards to depressive and anxiety disorders still remain an unanswered question.</p>
<p>In the present study, we investigated the neuronal mechanisms by which long-term isolation elicits depressive and anxiety-related behaviors. First, we examined whether long-term isolation increased depression and anxiety-related behaviors in mice and whether administration of OXT into the amygdala would ameliorate the isolation-induced depression and anxiety-related behaviors. Next, we explored the molecular and functional changes in the oxytocinergic circuits of the amygdala after long-term isolation.</p>
</sec>
<sec id="s1" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec>
<title>Animals</title>
<p>C57BL/6N mice (Orient Bio, Korea) were used in this study. Since the effect of oxytocin on stress-related behaviors and hormone secretion varies during the menstrual cycle (<xref ref-type="bibr" rid="B1">Altemus et al., 2001</xref>; <xref ref-type="bibr" rid="B26">Kotwica et al., 2004</xref>), only male mice were used. All experiments were approved by the Institutional Animal Care and Use Committee at Korea University College of Medicine (KOREA-2016-0203). Animals were housed under a 12-h light/dark cycle. Food and water were available <italic>ad libitum</italic>. Mice were either group housed or single housed in standard cages until the end of experimentation.</p>
</sec>
<sec>
<title>Isolation</title>
<p>Mice were subjected to isolation at the age of 6 weeks after living with same-sex siblings in a standard cage since weaning. Isolation involved removing same-sex siblings from the standard cage and placing an isolated mouse into an identically sized standard cage. The isolated mice were subjected to 5 weeks of continuous isolation.</p>
</sec>
<sec>
<title>Stereotaxic Injections</title>
<p>Using previously published procedures (<xref ref-type="bibr" rid="B22">Kim et al., 2011</xref>), drugs were injected with the use of a stereotaxic frame (Model 900, Kopf Instrument, United States) with ear bars. Coordinates according to <xref ref-type="bibr" rid="B36">Paxinos and Franklin (2004)</xref> were as follows (in mm, from bregma): CeA: A/P (rostrocaudal), −1.3; M/L (mediolateral), ±2.7; D/V (dorsoventral), −4.8 and lateral ventricle: A/P, −0.2; M/L, ±1.0; D/V, −2.3. Ketamine/xylazine (100 mg/kg and 10 mg/kg, respectively; i.p.) were used for anesthesia. Guide cannulas (26G, RWD, United States) were inserted through small holes drilled into the skull. A separate hole was drilled into the opposite position of the cannula insertion site on the skull. A tiny screw was inserted into the hole. Dental cement was applied to the skull for fixation of the guide cannulas. One week post-surgery, an internal cannula (30G, RWD, United States) connected to a polyethylene microtube was inserted through the guide cannula and secured in place with a fixing screw (RWD, United States). The polyethylene microtube was connected to a 10-μl gastight Hamilton syringe. Solutions were infused using the Hamilton syringe (1 μl/min) in freely moving mice. After the behavioral tests, mice were sacrificed to verify cannula placements. Animals with misplaced cannulas (17/132) were excluded from the analysis.</p>
</sec>
<sec>
<title>Drugs</title>
<p>Oxytocin was purchased from Sigma–Aldrich (United States). desGly-NH<sub>2</sub>-d(CH<sub>2</sub>)<sub>5</sub>[D-Tyr<sup>2</sup>,Thr<sup>4</sup>]OVT (OXT receptor antagonist, OXTRA) and d(CH<sub>2</sub>)<sub>5</sub>[Tyr(Me)<sup>2</sup>]AVP (vasopressin-1a receptor antagonist, V1aRA) were generously donated by Dr. Manning (The University of Toledo College of Medicine and Life Sciences, Maurice Manning) (<xref ref-type="bibr" rid="B29">Manning et al., 2012</xref>). All drugs were diluted to the final working concentrations from stock solutions on the day of experimentation. The solutions used in behavioral tests were dissolved in normal saline with final volumes adjusted to 2 μl. For electrophysiological experiments, OXT and OXTRA were dissolved in ACSF solution at 0.3 and 1 μM, respectively (<xref ref-type="bibr" rid="B18">Huber et al., 2005</xref>; <xref ref-type="bibr" rid="B47">Tang et al., 2014</xref>).</p>
</sec>
<sec>
<title>Behavioral Tests</title>
<p>Behavioral tests were performed as previously described (<xref ref-type="bibr" rid="B23">Kim et al., 2017</xref>). Since repeated tests affected behavioral test results, separate cohorts of mice completed each behavioral test. All the behavioral tests were begun 2 h after the light cycle had started. During experimentation, each mouse was concealed from the other mice. The forced swimming test (FST) and the sucrose preference test (SPT) were performed to measure depression-related behaviors. The open field test (OFT) and the elevated zero maze test (EZMT) were performed to measure anxiety-related behaviors.</p>
</sec>
<sec>
<title>The Forced Swimming Test</title>
<p>The mice were forced to swim for 15 min in a cylindrical glass tank (13-cm diameter) filled to a depth of 20 cm with tap water at a temperature of 22–25°C. The next day, the mice were subjected to a 6-min FST in the same tank and recorded using a video camera. The immobility time was analyzed using ANY-maze (Stoelting Co., United States).</p>
</sec>
<sec>
<title>The Sucrose Preference Test (SPT)</title>
<p>Two bottles were made available per cage, each containing either 200 ml of 1% sucrose (w/v) or 200 ml of tap water. After 12 h, the position of each bottle was switched for another 12 h. Preference (sucrose consumption ratio) was measured after 24 h as follows: (sucrose consumption)/(sucrose consumption + water consumption). Animals were returned to their home cages post-test.</p>
</sec>
<sec>
<title>The Open Field Test</title>
<p>The apparatus consisted of a gray arena (45 × 45 × 40 cm). A mouse was placed at the corner of the floor and the time each mouse spent in the center (center square area 22.5 cm × 22.5 cm), the number of center visits, and the total movement distance were measured using infrared recording for 30 min. Between trials, the arena was cleaned with 70% ethanol.</p>
</sec>
<sec>
<title>The Elevated Zero Maze Test</title>
<p>The maze comprised gray acrylic in a circular track 6-cm wide, 40 cm in diameter, and elevated 65 cm from the floor. The maze was divided into four quadrants of equal length containing two opposing open quadrants with clear acrylic curbs (1-cm high) and two opposing closed quadrants with gray acrylic walls (11-cm high). Animals were placed in the center of a closed quadrant and allowed to explore for 5 min. The percentage of time spent in the open quadrants and the number of head dips were recorded with an overhead video camera. Between trials, the maze was cleaned with 70% ethanol.</p>
<p>Experimenters were blinded to the drug treatment and all behavioral tests were performed after 20 min of drug administration. The drug concentrations used were determined based on previous studies (<xref ref-type="bibr" rid="B33">Neumann and Slattery, 2016</xref>).</p>
</sec>
<sec>
<title>Electrophysiology</title>
<sec>
<title>Slice Preparation</title>
<p>Brain slices were prepared as previously described (<xref ref-type="bibr" rid="B24">Kim et al., 2013</xref>). Briefly, coronal slices containing the CeA (300 μm) were obtained from 11- to 12-week-old mice using a vibrating microtome (Model 7000smz-2, Campden Instrument, United Kingdom) after isoflurane anesthesia and decapitation. The slices were cut with ice-cold artificial cerebrospinal fluid (ACSF) solution containing the following (in mM): 124 NaCl, 1.3 MgSO<sub>4</sub>, 3 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 26 NaHCO<sub>3</sub>, 2.4 CaCl<sub>2</sub>, and 10 glucose with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. For recovery, slices were incubated at 35.5°C for 60 min. All recordings were obtained within 8 h of recovery.</p>
</sec>
<sec>
<title>Intracellular Recordings</title>
<p>As previously described (<xref ref-type="bibr" rid="B22">Kim et al., 2011</xref>; <xref ref-type="bibr" rid="B15">Han et al., 2018</xref>), current- or voltage-clamp recordings were obtained from neurons in CeA-containing slices equilibrated for 1–12 h in the recording chamber. Micropipettes (Sutter Instruments, United States; tip diameter, 1.5–2.0 μm; 3–6 MΩ) pulled from borosilicate tubing (P-97; Sutter Instruments, United States) and filled with a KCl-containing internal solution (in mM: 120 KCl, 10 HEPES, 1 CaCl<sub>2</sub>, 2 MgCl<sub>2</sub>, 11 EGTA, 2 K<sub>2</sub>ATP, and adjusted at pH 7.2–7.3 using KOH) were used for whole-cell recordings, which were performed at 35–36°C. The signals from neurons amplified by Axoclamp-2B amplifier (bandwidth filter of 10 kHz for current-clamp recordings and 1 kHz for voltage-clamp recordings) were digitized and sampled at 50-μs intervals (Digidata 1320, pClamp 8.0; Molecular Devices, United States).</p>
</sec>
</sec>
<sec>
<title>Miniature Inhibitory Post Synaptic Current (mIPSC) Analysis</title>
<p>As previously described (<xref ref-type="bibr" rid="B40">Ryu et al., 2017</xref>), mIPSCs were recorded from neurons in the medial part of the CeA at a −80-mV holding potential in ACSF solution with 0.5-μM tetrodotoxin (TTX), 100-μM 2-amino-5-phosphonovaleric acid (AP5), and 20-μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) 5 min after whole-cell patching. The mIPSC data were analyzed using Mini Analysis (Synaptosoft, United States). The ratio of changes in mIPSC frequency or amplitude was calculated as follows: mIPSC frequency (or amplitude) after OXT treatment/mIPSC frequency (or amplitude) before OXT treatment. Recordings were excluded from analysis if the series resistance varied by more than 20%.</p>
</sec>
<sec>
<title>Quantitative Real-Time Polymerase Chain Reaction (RT-PCR)</title>
<p>The CeA- and paraventricular nucleus of hypothalamus- (PVN-) containing brain slices (300 μm) were obtained using Vibroslice (Model ROMA752, Campden Instruments, United Kingdom). The CeA or PVN was identified using a microscope and punched-out using 1-mm disposable punch biopsies. As previously described (<xref ref-type="bibr" rid="B14">Han et al., 2016a</xref>), the collected tissue was homogenized. RNA was extracted from the homogenized tissue using TRIzol Reagent (Life Technologies, United States), reverse-transcribed using M-MLV reverse transcriptase (Invitrogen, United States), and amplified by quantitative PCR with LightCycler 96 (Roche Diagnostics, Switzerland) and GoTaq qPCR Master Mix (Promega, United States), respectively, according to the manufacturer’s instructions. Primers are shown in <bold>Table <xref ref-type="table" rid="T1">1</xref></bold>.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>qPCR Primers.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Target gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">Forward primer (5′ - 3′)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Reverse primer (5′ - 3′)</th>
<th align="left" colspan="1" rowspan="1" valign="top">GenBank accession</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GAPDH</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAGGTCATCCCAGAGCRTGAA</td>
<td align="left" colspan="1" rowspan="1" valign="top">CTGCTTCACCACCTTCTTGA</td>
<td align="left" colspan="1" rowspan="1" valign="top">GU214026.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">GCACGGGTCAGTAGTGTCAA</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAGCTTCTTTGGGCGCATTG</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_001081147.1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oxytocin</td>
<td align="left" colspan="1" rowspan="1" valign="top">AGGAGAACTACCTGCCTTCG</td>
<td align="left" colspan="1" rowspan="1" valign="top">GGTATTCCCAGAAAGTGGGCT</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_011025.4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vasopressin-la receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">GTCCGAGGGAAGACAGCATC</td>
<td align="left" colspan="1" rowspan="1" valign="top">GATCTTGGCACGGGAAATGC</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_016847.2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Vasopressin</td>
<td align="left" colspan="1" rowspan="1" valign="top">TACGCTCTCCGCTTGTTTCC</td>
<td align="left" colspan="1" rowspan="1" valign="top">AAAACCGTCGTGGCACTC</td>
<td align="left" colspan="1" rowspan="1" valign="top">NM_009732.2</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Statistical Analysis</title>
<p>Data are expressed as mean ± SEM. All data were analyzed using unpaired <italic>t</italic>-tests, except for the data in <bold>Figures <xref ref-type="fig" rid="F1">1A,C</xref></bold>, <bold><xref ref-type="fig" rid="F2">2A,C</xref></bold>, <bold><xref ref-type="fig" rid="F3">3A,B</xref></bold>, <bold><xref ref-type="fig" rid="F6">6</xref></bold>. Data in <bold>Figures <xref ref-type="fig" rid="F1">1A,C</xref></bold>, <bold><xref ref-type="fig" rid="F2">2A,C</xref></bold> were analyzed using repeated measures two-way ANOVA, and <italic>post hoc</italic> analysis was performed using Bonferroni’s test. Data in <bold>Figures <xref ref-type="fig" rid="F3">3A,B</xref></bold> were analyzed using one-way ANOVA, and <italic>post hoc</italic> analysis was performed using Bonferroni’s test. Data in <bold>Figure <xref ref-type="fig" rid="F6">6</xref></bold> were analyzed using a paired <italic>t</italic>-test. <italic>p</italic> &lt; 0.05 was considered significant.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Isolated mice showed depression-related behaviors in the FST and the SPT. <bold>(A)</bold> Chronological changes in the immobility time of isolated and group-housed mice in the FST during the 5-week period. <bold>(B)</bold> Comparison of the immobility time between isolated (<italic>n</italic> = 10) and group-housed mice (<italic>n</italic> = 10) in the FST after the 5-week isolation. <bold>(C)</bold> Chronological changes in the sucrose consumption ratio of isolated and group-housed mice in the SPT during the 5-week period. <bold>(D)</bold> Comparison of the sucrose consumption ratio between the isolated (<italic>n</italic> = 12) and group-housed mice (<italic>n</italic> = 10) in the SPT after the 5-week isolation. <sup>∗</sup><italic>p</italic> &lt; 0.05, ns; not significant, repeated measures two-way ANOVA followed by <italic>post hoc</italic> Bonferroni’s test in <bold>(A,C)</bold> and unpaired student’s <italic>t</italic>-test in <bold>(B,D)</bold>. Error bars represent SEM. FST; forced swimming test; SPT; sucrose preference test.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g001"></graphic>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Isolated mice exhibited anxiety-related behaviors in the OFT and the EZMT. <bold>(A)</bold> Chronological changes in time spent in open quadrants by isolated and group-housed mice in the EZMT during the 5-week period. <bold>(B)</bold> Comparison of the time spent in open quadrants between isolated (<italic>n</italic> = 12) and group-housed (<italic>n</italic> = 12) mice after the 5-week isolation in the EZMT. <bold>(C)</bold> Chronological changes in the time spent in the center between the isolated and group-housed mice in the OFT during the 5-week period. <bold>(D)</bold> Comparison of the time spent in the center between the isolated (<italic>n</italic> = 12) and group-housed mice (<italic>n</italic> = 12) after the 5-week isolation in the OFT. <sup>∗</sup><italic>p</italic>
<italic>&lt;</italic> 0.05, <sup>∗∗∗</sup><italic>p</italic> &lt; 0.0001, ns, not significant, repeated measures two-way ANOVA followed by <italic>post hoc</italic> Bonferroni’s test in <bold>(A,C)</bold> and unpaired student’s <italic>t</italic>-test in <bold>(B,D)</bold>. Error bars represent SEM. EZMT; elevated zero maze test, OFT; open field test.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g002"></graphic>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Intra-CeA injection of OXT, but not ICV injection, attenuated isolation-induced depression and anxiety-related behaviors via OXTR in the FST and EZMT, respectively. <bold>(A)</bold> Immobility time of isolated mice after intra-CeA injection of OXT (0.5 μg, <italic>n</italic> = 12), OXT + OXTRA (1 μg, <italic>n</italic> = 10), and OXT + V1aRA (1 μg, <italic>n</italic> = 10) was compared to that after vehicle injection (<italic>n</italic> = 12) in the FST. <bold>(B)</bold> Time spent in the open quadrants by isolated mice after intra-CeA injection of OXT (0.5 μg, <italic>n</italic> = 12), OXT + OXTRA (1 μg, <italic>n</italic> = 9), and OXT + V1aRA (1 μg, <italic>n</italic> = 8) was compared to that after vehicle injection (<italic>n</italic> = 10) in the EZMT. <bold>(C)</bold> Immobility time of isolated mice after ICV injection of OXT (0.5 μg, <italic>n</italic> = 6) was compared to that after vehicle injection (<italic>n</italic> = 7) in the FST. <bold>(D)</bold> Time spent in the open quadrants by the isolated mice after ICV injection of OXT (0.5 μg, <italic>n</italic> = 8) was compared to that after vehicle injection (<italic>n</italic> = 8) in the EZMT. <sup>∗</sup><italic>p</italic> &lt; 0.05, ns, not significant, one-way ANOVA followed by <italic>post hoc</italic> Bonferroni’s test in <bold>(A,B)</bold> and unpaired student’s <italic>t</italic>-test in <bold>(C,D)</bold>. Error bars represent SEM. CeA, central amygdala; OXT, oxytocin; OXTR, oxytocin receptor; V1aRA, vasopressin-1a receptor antagonist; OXTRA, oxytocin receptor antagonist; ICV, intracerebroventricular.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g003"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Results</title>
<sec>
<title>Long-Term Isolation Induced Depression-Related Behaviors in Male Mice</title>
<p>To investigate whether isolation induced depression in mice, we measured depression-related behaviors using the FST and the SPT every week for 5 weeks. For the first 3 weeks, isolation did not significantly increase depression-related behaviors such as learned helplessness and anhedonia in isolated mice (<bold>Figures <xref ref-type="fig" rid="F1">1A,C</xref></bold>). However, after 4 weeks of isolation, depression-related behaviors began to develop in isolated mice compared to group-housed mice as measured by both the FST and the SPT (<bold>Figures <xref ref-type="fig" rid="F1">1A,C</xref></bold>). Given that repeated tests influenced behavioral outcomes (<bold>Figure <xref ref-type="fig" rid="F1">1A</xref></bold>) and neural circuits (<xref ref-type="bibr" rid="B46">Takao et al., 1995</xref>; <xref ref-type="bibr" rid="B2">Badowska-Szalewska et al., 2010</xref>) for depression, we measured depression-related behaviors for the first time after the 5-week isolation in another group of mice. In both the FST and the SPT, depression-related behaviors significantly increased in isolated mice compared to group-housed mice after the 5-week isolation (<bold>Figures <xref ref-type="fig" rid="F1">1B,D</xref></bold>). These results demonstrated that 5 weeks of isolation induced depression-related behaviors in male mice.</p>
</sec>
<sec>
<title>Long-Term Isolation Elicited Anxiety-Related Behaviors in Male Mice</title>
<p>To examine whether isolation induced anxiety, we measured anxiety-related behaviors using the EZMT and the OFT every week for 5 weeks. In the EZMT and the OFT, for the first 2 weeks, isolation did not significantly elevate anxiety-related behavior as measured by the time spent in the open quadrants and center, respectively (<bold>Figures <xref ref-type="fig" rid="F2">2A,C</xref></bold>). However, after 3 weeks of isolation, anxiety-related behaviors started to develop in isolated mice compared to group-housed mice as measured by both the EZMT and the OFT (<bold>Figures <xref ref-type="fig" rid="F2">2A,C</xref></bold>). Since repeated tests altered the behavioral results for the measurement of anxiety in group-housed mice (<bold>Figures <xref ref-type="fig" rid="F2">2A,C</xref></bold>), we measured anxiety-related behaviors for the first time after the 5-week isolation in another group of mice. In both the EZMT and the OFT, after the 5-week isolation, anxiety-related behaviors significantly increased in the isolated mice compared to group-housed mice (<bold>Figures <xref ref-type="fig" rid="F2">2B,D</xref></bold> and <bold>Supplementary Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref></bold>). These results showed that 5 weeks of isolation induced anxiety-related behaviors in male mice as well.</p>
</sec>
<sec>
<title>OXT Administration Into the CeA, but Not Intracerebroventricular Injection, Ameliorated Isolation-Induced Depression and Anxiety-Related Behaviors via OXTR</title>
<p>The amygdala plays a critical role in the pathophysiology of anxiety disorders and is associated with the development of subtype of depressive disorders (<xref ref-type="bibr" rid="B45">Slattery and Neumann, 2010b</xref>; <xref ref-type="bibr" rid="B33">Neumann and Slattery, 2016</xref>). OXT has been reported to reduce anxiety-related behaviors (<xref ref-type="bibr" rid="B33">Neumann and Slattery, 2016</xref>). We therefore explored whether intra-CeA injection of OXT reduced isolation-induced depression and anxiety-related behaviors in isolated mice. Intra-CeA administration of OXT (0.5 μg) attenuated isolation-induced depression and anxiety-related behaviors in the FST and the EZMT, respectively (<bold>Figures <xref ref-type="fig" rid="F3">3A,B</xref></bold>). Since OXT binds to several receptors such as vasopressin receptors as well as OXTR, and both OXTR and vasopressin-1a receptor (V1aR) are known to modulate social and emotional behaviors (<xref ref-type="bibr" rid="B30">Meyer-Lindenberg et al., 2011</xref>; <xref ref-type="bibr" rid="B4">Benarroch, 2013</xref>), we used OXTRA and V1aRA to determine the specific receptor that mediated OXT-induced antidepressant and anxiolytic effects. In the FST and the EZMT, co-administration of OXT (0.5 μg) with OXTRA (1 μg) into the CeA did not rescue isolation-induced depression and anxiety-related behaviors in the FST and the EZMT, respectively (<bold>Figures <xref ref-type="fig" rid="F3">3A,B</xref></bold>). However, in both tests, co-administration of OXT (0.5 μg) with V1aRA (1 μg) attenuated isolation-induced depression and anxiety-related behaviors (<bold>Figures <xref ref-type="fig" rid="F3">3A,B</xref></bold>). We then administered the same dose OXT (0.5 μg) into the lateral ventricles to assess whether OXT acted on the CeA to exert its antidepressant and anxiolytic effects. The same dose of intracerebroventricular (ICV) injection of OXT did not ameliorate isolation-induced depression and anxiety-related behaviors (<bold>Figures <xref ref-type="fig" rid="F3">3C,D</xref></bold>). These findings implied that OXT acted on the CeA as an antidepressant and anxiolytic via OXTR.</p>
</sec>
<sec>
<title>OXTR but Not V1aR mRNA Transcription in the CeA Was Reduced After the 5-Week Isolation</title>
<p>Given that social isolation was reported to modify OXTR and V1aR mRNA transcription in the hypothalamus (<xref ref-type="bibr" rid="B37">Pournajafi-Nazarloo et al., 2013</xref>) and OXT acts on the CeA as an antidepressant and anxiolytic (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), we thus examined mRNA transcription of OXT/vasopressin circuits from the PVN to the CeA. OXTR mRNA transcription was significantly down-regulated in the CeA after the 5-week isolation (<bold>Figure <xref ref-type="fig" rid="F4">4A</xref></bold>) but V1aR mRNA transcription remained unchanged (<bold>Figure <xref ref-type="fig" rid="F4">4B</xref></bold>). These results were consistent with our previous findings that OXT acted on the CeA as an antidepressant and anxiolytic via OXTR, not V1aR. To interrogate the changes in OXT and vasopressin production after long-term isolation, we examined OXT and hypothalamic vasopressin mRNA transcription. No significant differences were observed in OXT and vasopressin mRNA transcription in the PVN between the isolated and group-housed mice (<bold>Figures <xref ref-type="fig" rid="F4">4C,D</xref></bold>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Relative mRNA transcription of OXTR in the CeA, but not that of V1aR, was decreased in isolated mice. <bold>(A)</bold> Comparison of OXTR mRNA transcription between isolated (<italic>n</italic> = 11) and group-housed (<italic>n</italic> = 8) mice in the CeA. <bold>(B)</bold> Comparison of V1aR mRNA transcription isolated (<italic>n</italic> = 11) and group-housed (<italic>n</italic> = 8) mice in the CeA. <bold>(C)</bold> Comparison of OXT mRNA transcription between isolated (<italic>n</italic> = 9) and group-housed (<italic>n</italic> = 8) mice in the PVN. <bold>(D)</bold> Comparison of AVP mRNA transcription between isolated (<italic>n</italic> = 9) and group-housed (<italic>n</italic> = 8) mice in the PVN. <sup>∗</sup><italic>p</italic>
<italic>&lt;</italic> 0.05, ns, not significant, unpaired student’s <italic>t</italic>-test. Error bars represent SEM. OXTR, oxytocin receptor; V1aR, vasopressin-1a receptor; OXT, oxytocin; AVP, vasopressin; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; CeA, central amygdala.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g004"></graphic>
</fig>
</sec>
<sec>
<title>Long-Term Isolation Reduced Inhibitory Synaptic Transmission in the CeA</title>
<p>Oxytocin signaling has been known to modulate γ-aminobutyric acid (GABA)-ergic circuits in the lateral part of the CeA and inhibit neurons in the medial part of the CeA through the GABAergic projections (<xref ref-type="bibr" rid="B18">Huber et al., 2005</xref>; <xref ref-type="bibr" rid="B48">Viviani et al., 2011</xref>; <xref ref-type="bibr" rid="B25">Knobloch et al., 2012</xref>), We therefore hypothesized that the reduced OXTR mRNA transcription after long-term isolation may result in functional changes in CeA inhibitory signaling. To test this hypothesis, we examined the effects of long-term isolation on inhibitory synaptic transmission in the medial part of the CeA (CeM). In studying the inhibitory synaptic transmission, we blocked all action potential-driven synaptic events by including tetrodotoxin (TTX) in the slice perfusion medium. This experimental strategy allowed us to focus on mIPSC, the changes in the frequency and amplitude of which would indicate changes in synaptic transmission originating pre- and post-synaptically. Our results demonstrated that mIPSC frequency in the CeM was significantly decreased in isolated mice (0.77 ± 0.1 Hz, <italic>n</italic> = 12) compared to group-housed mice (1.47 ± 0.17 Hz, <italic>n</italic> = 11) (<bold>Figures <xref ref-type="fig" rid="F5">5A,B</xref></bold>). However, the mIPSC amplitude in the CeM was not significantly changed after long-term isolation (isolated mice, 22.7 ± 1.1 pA, <italic>n</italic> = 12; group-housed mice, 24.4 ± 2.5 pA, <italic>n</italic> = 11) (<bold>Figures <xref ref-type="fig" rid="F5">5A,C</xref></bold>). These results suggested that long-term isolation attenuated inhibitory synaptic transmission in the CeM via reduction of GABA release from presynaptic terminals.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Inhibitory synaptic transmission of the CeA was reduced in isolated mice. <bold>(A)</bold> Representative traces of mIPSCs recorded from the CeA of an isolated mouse (left) and a group-housed mouse (right). <bold>(B)</bold> Comparison of mIPSC frequency between isolated (<italic>n</italic> = 12) and group-housed (<italic>n</italic> = 11) mice. <bold>(C)</bold> Comparison of mIPSC amplitude between isolated (<italic>n</italic> = 12) and group-housed (<italic>n</italic> = 11) mice. <sup>∗∗</sup><italic>p</italic> &lt; 0.005, ns, not significant, unpaired student’s <italic>t</italic>-test. Dot represents each cell. Error bars represent SEM. CeA, central amygdala; mIPSC, miniature inhibitory post synaptic currents.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g005"></graphic>
</fig>
</sec>
<sec>
<title>OXT Rescued the Decreased Local GABAergic Synaptic Transmission in the CeA of Isolated Mice via OXTR</title>
<p>As OXT administration rescued isolation-induced depression and anxiety-related behaviors (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>), we investigated whether OXT treatment restored the isolation-induced decrement of CeM inhibitory synaptic transmission. Analysis of mIPSC recordings from isolated mice showed that OXT increased the mIPSC frequency (<bold>Figure <xref ref-type="fig" rid="F6">6A</xref></bold>) from 0.75 ± 0.08 to 0.89 ± 0.09 Hz (<italic>n</italic> = 11) in the CeM but did not alter the mIPSC amplitude (<bold>Figure <xref ref-type="fig" rid="F6">6B</xref></bold>, from 25.6 ± 1.3 to 26.9 ± 1.7 Hz, <italic>n</italic> = 11). To interrogate the effects of down-regulated OXTR mRNA transcription on possible functional changes in CeM inhibitory synaptic transmission, we compared the extent of OXT-induced changes between isolated and group-housed mice. The increase in the mIPSC frequency after OXT treatment, but not in the mIPSC amplitude, was greater in group-housed mice than in isolated mice (<bold>Figure <xref ref-type="fig" rid="F7">7A,B</xref></bold>). We also observed that co-application of OXT with OXTRA blocked the OXT-induced increase in the mIPSC frequency in the CeM of isolated mice (<bold>Figures <xref ref-type="fig" rid="F6">6C,D</xref></bold>). Taken together, these results suggested that in accordance with the behavioral changes, OXT treatment restored the isolation-induced decrement of inhibitory synaptic transmission in the CeM via OXTR. Furthermore, the decrease in inhibitory synaptic transmission after long-term isolation could result in part from the reduction of OXTR that mediates the excitatory effect of OXT on the inhibitory GABAergic neurons innervating the cells.</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Oxytocin treatment restored the reduced inhibitory synaptic transmission of the CeA of isolated mice via OXTR. <bold>(A)</bold> Representative traces of mIPSCs recorded from the CeA of isolated mice before treatment (left) and 5 min after OXT treatment (right). <bold>(B)</bold> Comparison of mIPSC frequency (left) and amplitude (right) between pre- and post-treatment with OXT in isolated mice (<italic>n</italic> = 11). <bold>(C)</bold> Representative traces of mIPSCs recorded from the CeA of isolated mice before treatment (left) and 5 min after OXT + OXTRA treatment (right). <bold>(D)</bold> Comparison of mIPSC frequency (left) and amplitude (right) between pre- and post-treatment with OXT + OXTRA in isolated mice (<italic>n</italic> = 11). <sup>∗∗</sup><italic>p</italic> &lt; 0.005, ns, not significant, paired <italic>t</italic>-test. Dot represents each cell. Error bars represent SEM. OXT, oxytocin; CeA, central amygdala; OXTR, oxytocin receptor; mIPSC, miniature inhibitory post synaptic currents; OXTRA, oxytocin receptor antagonist.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g006"></graphic>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The OXT-induced increase in inhibitory synaptic transmission was greater in group-housed mice than in isolated mice. <bold>(A)</bold> Comparison of the OXT-induced change in mIPSC frequency between isolated (<italic>n</italic> = 11) and group-housed (<italic>n</italic> = 7) mice. <bold>(B)</bold> Comparison of the OXT-induced change in mIPSC amplitude between isolated (<italic>n</italic> = 11) and group-housed (<italic>n</italic> = 7) mice. <sup>∗</sup><italic>p</italic> &lt; 0.05, ns; not significant, unpaired student’s <italic>t</italic>-test. Dot represents each cell. Error bars represent SEM. OXT, oxytocin; mIPSC, miniature inhibitory post synaptic current.</p>
</caption>
<graphic xlink:href="fnmol-11-00246-g007"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Discussion</title>
<p>The main findings of this study are: (1) that long-term isolation down-regulated mRNA transcription of OXTR in the CeA, (2) that long-term isolation reduced GABAergic synaptic transmission in the CeA, and (3) that OXT treatment restored the functional changes in inhibitory synaptic transmission in the CeA and also rescued the behavioral deficits in the FST and the EZMT produced by long-term isolation via OXTR.</p>
<p>Here, we revealed that mice showed significantly increased depression and anxiety-related behaviors after more than 4 weeks of isolation (<bold>Figures <xref ref-type="fig" rid="F1">1</xref></bold>, <bold><xref ref-type="fig" rid="F2">2</xref></bold>). These findings agree with previous studies showing that social isolation affected depression and anxiety-related behaviors. A week of isolation increased anxiety-related behaviors, but did not affect depression-related behaviors (<xref ref-type="bibr" rid="B27">Kwak et al., 2009</xref>). After isolation followed by an enriched environment, isolated mice developed anxiety-related behaviors in the OFT, but not depression-related behaviors in the learned-helplessness paradigm (<xref ref-type="bibr" rid="B6">Chourbaji et al., 2005</xref>). The discrepancy between previous studies and our data may be attributed to the duration of isolation and the enriched environment, as prolonged isolation with impoverished circumstances was reported to elicit both depression- and anxiety-related behaviors (<xref ref-type="bibr" rid="B19">Ieraci et al., 2016</xref>).</p>
<p>Oxytocin has been known to act as an anxiolytic (<xref ref-type="bibr" rid="B33">Neumann and Slattery, 2016</xref>) and the CeA has been implicated in anxiety and fear responses (<xref ref-type="bibr" rid="B7">Ciocchi et al., 2010</xref>; <xref ref-type="bibr" rid="B25">Knobloch et al., 2012</xref>), but the loci of the anxiolytic action of OXT in the context of social isolation remain unclear. Moreover, a few human studies have indicated that OXT has anti-depressant properties (<xref ref-type="bibr" rid="B41">Scantamburlo et al., 2011</xref>; <xref ref-type="bibr" rid="B8">Cochran et al., 2013</xref>). We aimed to determine whether OXT was involved with isolation-induced behavioral abnormalities such as depression and anxiety-related behaviors and whether OXT acts on the CeA that contains abundant expression of OXTR (<xref ref-type="bibr" rid="B52">Yoshida et al., 2009</xref>; <xref ref-type="bibr" rid="B5">Boccia et al., 2013</xref>). We therefore compared the brain site-specific effects of OXT on isolation-induced abnormal behaviors. Consistent with previous studies (<xref ref-type="bibr" rid="B44">Slattery and Neumann, 2010a</xref>; <xref ref-type="bibr" rid="B55">Zoicas et al., 2014</xref>), ICV injection of OXT did not affect isolation-induced abnormal psychiatric behaviors. However, administration of the same dose of OXT into the CeA or ICV injection of a dose 10 times higher (5 μg) (data not shown) attenuated isolation-induced behavioral deficits. Since OXT binds to vasopressin receptors as well as OXTR (<xref ref-type="bibr" rid="B29">Manning et al., 2012</xref>), we administered specific receptor antagonists to identify which receptor mediated the anxiolytic and antidepressant effects of OXT. Consistent with previous studies demonstrating that OXTR is more related to the relief of social stress than vasopressin receptors (<xref ref-type="bibr" rid="B4">Benarroch, 2013</xref>), we confirmed that OXT exerted its anti-depressant and anxiolytic effects via OXTR, not V1aR. Taken together, these findings suggested that OXT acted specifically on the CeA via OXTR to modulate depression and anxiety-related behaviors. It is possible that the lack of effects of OXT in human studies is due to the insufficient delivery of OXT into the CeA.</p>
<p>Expression and transcription of OXTR is under more complicating regulation than other G-protein coupled receptors (<xref ref-type="bibr" rid="B54">Zingg and Laporte, 2003</xref>). For example, prolonged stimulation of OXTR by an agonist induces OXTR down-regulation (<xref ref-type="bibr" rid="B12">Gimpl and Fahrenholz, 2001</xref>). Social isolation was reported to be associated with down-regulation of hypothalamic OXTR mRNA transcription (<xref ref-type="bibr" rid="B37">Pournajafi-Nazarloo et al., 2013</xref>). Moreover, deprivation of social interactions and chronic stress produced by isolation are involved with not only decrease but also increase in the secretion of OXT (<xref ref-type="bibr" rid="B37">Pournajafi-Nazarloo et al., 2013</xref>; <xref ref-type="bibr" rid="B16">Han et al., 2016b</xref>). Thus, our observation that the mRNA transcription of OXTR, but not that of V1aRA, was reduced in the CeA after the 5-week isolation (<bold>Figures <xref ref-type="fig" rid="F4">4A,B</xref></bold>) may be attributed to two possible scenarios. First, the altered secretion of OXT after long-term isolation possibly decreased OXTR mRNA transcription in the CeA. Alternatively, social isolation might influence the transcription of OXTR mRNA regardless of the change in OXT secretion.</p>
<p>Oxytocinergic circuits from the hypothalamus have been known to modulate GABA signaling in the CeA (<xref ref-type="bibr" rid="B18">Huber et al., 2005</xref>; <xref ref-type="bibr" rid="B48">Viviani et al., 2011</xref>; <xref ref-type="bibr" rid="B25">Knobloch et al., 2012</xref>) and decreases in OXTR expression modulate presynaptic GABA release (<xref ref-type="bibr" rid="B38">Ripamonti et al., 2017</xref>). In the current study, we found that OXTR mRNA in the CeA is down-regulated after long-term isolation and OXT rescues the isolation-induced depression- and anxiety-related behaviors by acting on OXTR in the CeA. To test the hypothesis that the alteration of GABAergic transmission in CeA neurons resulting from OXTR down-regulation underlies the emergence of the isolation-induced depression- and anxiety-related behaviors, we performed whole-cell patch-clamp recordings in acutely prepared brain slices from isolated and group-housed mice. From these experiments, we learned that mIPSCs in CeA neurons were lower in frequency in the case of isolated, than group-housed, mice and that OXT, by acting through OXTR, increased the frequency of mIPSC more robustly in the group-house mice. These results indicate that long-term isolation may elicit the depression- and anxiety-related behaviors by down-regulating the OXTR, which is excitatory to the inhibitory GABAergic neurons innervating CeA neurons, and hence disinhibiting these cells. However, we could not exclude the possibility that other than OXT, signaling molecules such as serotonin and catecholamine could also contribute to isolation-induced circuit plasticity in the CeA (<xref ref-type="bibr" rid="B21">Karkhanis et al., 2015</xref>; <xref ref-type="bibr" rid="B53">Yu et al., 2018</xref>).</p>
<p>Our data from electrophysiological experiments partly disagree with the findings of <xref ref-type="bibr" rid="B18">Huber et al. (2005)</xref>. The IPSCs of CeA cells recorded in the absence of TTX by these authors were much greater in amplitude and frequency than the ones detected in our experiments. Moreover, the increase in IPSC frequency induced by the application of OXT was much more robust in <xref ref-type="bibr" rid="B18">Huber et al. (2005)</xref> experiments. Apparently, these discrepancies might be due to the fact that <xref ref-type="bibr" rid="B18">Huber et al. (2005)</xref> recorded spontaneous IPSCs, whereas we obtained mIPSCs after the blockade of all action potential-dependent synaptic events with TTX. In this context, it is interesting to note that even in the presence of TTX, OXTR activation can depolarize the membrane potential, thus leading to action potential-independent GABA release (<xref ref-type="bibr" rid="B9">Cohen et al., 1992</xref>; <xref ref-type="bibr" rid="B32">Murai et al., 1998</xref>; <xref ref-type="bibr" rid="B17">Harden and Frazier, 2016</xref>).</p>
</sec>
<sec>
<title>Conclusion</title>
<p>In conclusion, our data reveal a neural mechanism underlying isolation-induced depressive and anxiety behaviors. We propose that the decrease in OXTR mRNA transcription after long-term isolation may induce depressive and anxiety disorders by reducing GABA release and consequently, disinhibiting CeA neurons. These results imply that modulation of OXTR signaling and expression in the CeA is a promising target for developing treatments for depressive and anxiety disorders.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>RH and Y-BK equally contributed to this manuscript. HN and YK conceived the idea, obtained funding for the study, and guided the project. RH performed the behavioral tests and stereotaxic injection and Y-BK performed whole-cell path clamp. E-HP performed and analyzed stereotaxic injection and behavioral results. JK performed behavioral tests. CR performed and analyzed electrophysiology results. HYK and JL performed and analyzed qPCR. KP and CS performed stereotaxic and analyzed electrophysiology data, respectively. HK and SB conceived the idea and analyzed the results. YK conceived the idea. RH, Y-BK, HJK, and HN wrote the manuscript. All authors gave final approval and agree to be accountable for all aspects of the work.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This research was supported by Korea University Future Research grant (K1721361), National Research Foundation of Korea (NRF) grants funded by the Korean government (Ministry of Science, Information and Communications Technology and Future Planning) (2016R1D1A1B03932771 to Y-BK and 2017R1A2B2002277 to YK), and the ChungYang, Cha Young Sun, M.D., and Jang Hi Joo Yeu Sa Memorial Fund.</p>
</fn>
</fn-group>
<ack>
<p>We would like to thank Dr. Morris Manning for generous donation of the neuropeptide receptor antagonists and Dr. Hyun Jung Kim for helpful comments on immunohistochemistry.</p>
</ack>
<sec>
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2018.00246/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fnmol.2018.00246/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<label>FIGURE S1</label>
<caption>
<p>Isolated mice showed anxiety-related behaviors without hyperactivity in the OFT and anxiety-related behaviors in the EZMT after 5-week isolation. <bold>(A)</bold> Comparison of the number of center visits between isolated (<italic>n</italic> = 12) and group-housed mice (<italic>n</italic> = 12) in the OFT after the 5-week isolation. <bold>(B)</bold> Comparison of the total movement distance between isolated (<italic>n</italic> = 12) and group-housed mice (<italic>n</italic> = 12) in the OFT after the 5-week isolation. <bold>(C)</bold> Comparison of the number of head dips between isolated (<italic>n</italic> = 12) and group-housed mice (<italic>n</italic> = 12) in the EZMT after the 5-week isolation. <sup>∗</sup><italic>p</italic> &lt; 0.05, <sup>∗∗∗</sup><italic>p</italic> &lt; 0.001, ns, not significant, unpaired student’s <italic>t</italic>-test. Error bars represent SEM.</p>
</caption>
<media xlink:href="Image_1.TIF">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altemus</surname><given-names>M.</given-names></name><name><surname>Roca</surname><given-names>C.</given-names></name><name><surname>Galliven</surname><given-names>E.</given-names></name><name><surname>Romanos</surname><given-names>C.</given-names></name><name><surname>Deuster</surname><given-names>P.</given-names></name></person-group> (<year>2001</year>). <article-title>Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the menstrual cycle.</article-title>
<source/><italic>J. Clin. Endocrinol. Metab.</italic>
<volume>86</volume>
<fpage>2525</fpage>–<lpage>2530</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.86.6.7596</pub-id>
<pub-id pub-id-type="pmid">11397850</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badowska-Szalewska</surname><given-names>E.</given-names></name><name><surname>Spodnik</surname><given-names>E.</given-names></name><name><surname>Klejbor</surname><given-names>I.</given-names></name><name><surname>Morys</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of chronic forced swim stress on hippocampal brain-derived neutrophic factor (BDNF) and its receptor (TrkB) immunoreactive cells in juvenile and aged rats.</article-title>
<source/><italic>Acta Neurobiol. Exp.</italic>
<volume>70</volume>
<fpage>370</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="pmid">21196945</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballenger</surname><given-names>J. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Clinical guidelines for establishing remission in patients with depression and anxiety.</article-title>
<source/><italic>J. Clin. Psychiatry</italic>
<volume>60</volume>(Suppl. 22), <fpage>29</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="pmid">10634353</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benarroch</surname><given-names>E. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions.</article-title>
<source/><italic>Neurology</italic>
<volume>80</volume>
<fpage>1521</fpage>–<lpage>1528</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e31828cfb15</pub-id>
<pub-id pub-id-type="pmid">23589638</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccia</surname><given-names>M. L.</given-names></name><name><surname>Petrusz</surname><given-names>P.</given-names></name><name><surname>Suzuki</surname><given-names>K.</given-names></name><name><surname>Marson</surname><given-names>L.</given-names></name><name><surname>Pedersen</surname><given-names>C. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Immunohistochemical localization of oxytocin receptors in human brain.</article-title>
<source/><italic>Neuroscience</italic>
<volume>253</volume>
<fpage>155</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.08.048</pub-id>
<pub-id pub-id-type="pmid">24012742</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chourbaji</surname><given-names>S.</given-names></name><name><surname>Zacher</surname><given-names>C.</given-names></name><name><surname>Sanchis-Segura</surname><given-names>C.</given-names></name><name><surname>Spanagel</surname><given-names>R.</given-names></name><name><surname>Gass</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Social and structural housing conditions influence the development of a depressive-like phenotype in the learned helplessness paradigm in male mice.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>164</volume>
<fpage>100</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2005.06.003</pub-id>
<pub-id pub-id-type="pmid">16046006</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciocchi</surname><given-names>S.</given-names></name><name><surname>Herry</surname><given-names>C.</given-names></name><name><surname>Grenier</surname><given-names>F.</given-names></name><name><surname>Wolff</surname><given-names>S. B.</given-names></name><name><surname>Letzkus</surname><given-names>J. J.</given-names></name><name><surname>Vlachos</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Encoding of conditioned fear in central amygdala inhibitory circuits.</article-title>
<source/><italic>Nature</italic>
<volume>468</volume>
<fpage>277</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1038/nature09559</pub-id>
<pub-id pub-id-type="pmid">21068837</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cochran</surname><given-names>D. M.</given-names></name><name><surname>Fallon</surname><given-names>D.</given-names></name><name><surname>Hill</surname><given-names>M.</given-names></name><name><surname>Frazier</surname><given-names>J. A.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.</article-title>
<source/><italic>Harv. Rev. Psychiatry</italic>
<volume>21</volume>
<fpage>219</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1097/HRP.0b013e3182a75b7d</pub-id>
<pub-id pub-id-type="pmid">24651556</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>G. A.</given-names></name><name><surname>Doze</surname><given-names>V. A.</given-names></name><name><surname>Madison</surname><given-names>D. V.</given-names></name></person-group> (<year>1992</year>). <article-title>Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons.</article-title>
<source/><italic>Neuron</italic>
<volume>9</volume>
<fpage>325</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(92)90171-9</pub-id><pub-id pub-id-type="pmid">1497896</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>England</surname><given-names>M. J. E.</given-names></name><name><surname>Sim</surname><given-names>L. J.</given-names></name></person-group> (<year>2009</year>). <source/><italic>Depression in Parents, Parenting, and Children: Opportunities to Improve Identification, Treatment, and Prevention</italic>.
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>National Academies Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fava</surname><given-names>M.</given-names></name><name><surname>Rankin</surname><given-names>M. A.</given-names></name><name><surname>Wright</surname><given-names>E. C.</given-names></name><name><surname>Alpert</surname><given-names>J. E.</given-names></name><name><surname>Nierenberg</surname><given-names>A. A.</given-names></name><name><surname>Pava</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Anxiety disorders in major depression.</article-title>
<source/><italic>Compr. Psychiatry</italic>
<volume>41</volume>
<fpage>97</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/S0010-440X(00)90140-8</pub-id><pub-id pub-id-type="pmid">10741886</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimpl</surname><given-names>G.</given-names></name><name><surname>Fahrenholz</surname><given-names>F.</given-names></name></person-group> (<year>2001</year>). <article-title>The oxytocin receptor system: structure, function, and regulation.</article-title>
<source/><italic>Physiol. Rev.</italic>
<volume>81</volume>
<fpage>629</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.2001.81.2.629</pub-id>
<pub-id pub-id-type="pmid">11274341</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grav</surname><given-names>S.</given-names></name><name><surname>Hellzen</surname><given-names>O.</given-names></name><name><surname>Romild</surname><given-names>U.</given-names></name><name><surname>Stordal</surname><given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Association between social support and depression in the general population: the HUNT study, a cross-sectional survey.</article-title>
<source/><italic>J. Clin. Nurs.</italic>
<volume>21</volume>
<fpage>111</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2702.2011.03868.x</pub-id>
<pub-id pub-id-type="pmid">22017561</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>R. T.</given-names></name><name><surname>Back</surname><given-names>S. K.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>H. Y.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2016a</year>). <article-title>Formaldehyde-induced aggravation of pruritus and dermatitis is associated with the elevated expression of Th1 cytokines in a Rat model of atopic dermatitis.</article-title>
<source/><italic>PLoS One</italic>
<volume>11</volume>:<issue>e0168466</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0168466</pub-id>
<pub-id pub-id-type="pmid">28005965</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>R. T.</given-names></name><name><surname>Kim</surname><given-names>H. B.</given-names></name><name><surname>Kim</surname><given-names>Y. B.</given-names></name><name><surname>Choi</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>G. Y.</given-names></name><name><surname>Lee</surname><given-names>P. R.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons.</article-title>
<source/><italic>Korean J. Physiol. Pharmacol.</italic>
<volume>22</volume>
<fpage>173</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.4196/kjpp.2018.22.2.173</pub-id>
<pub-id pub-id-type="pmid">29520170</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>R. T.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>S. B.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Back</surname><given-names>S. K.</given-names></name><etal></etal></person-group> (<year>2016b</year>). <article-title>Brief isolation changes nociceptive behaviors and compromises drug tests in mice.</article-title>
<source/><italic>Pain Pract.</italic>
<volume>16</volume>
<fpage>749</fpage>–<lpage>757</lpage>. <pub-id pub-id-type="doi">10.1111/papr.12325</pub-id>
<pub-id pub-id-type="pmid">26212903</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harden</surname><given-names>S. W.</given-names></name><name><surname>Frazier</surname><given-names>C. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxytocin depolarizes fast-spiking hilar interneurons and induces GABA release onto mossy cells of the rat dentate gyrus.</article-title>
<source/><italic>Hippocampus</italic>
<volume>26</volume>
<fpage>1124</fpage>–<lpage>1139</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.22595</pub-id>
<pub-id pub-id-type="pmid">27068005</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>D.</given-names></name><name><surname>Veinante</surname><given-names>P.</given-names></name><name><surname>Stoop</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.</article-title>
<source/><italic>Science</italic>
<volume>308</volume>
<fpage>245</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1126/science.1105636</pub-id>
<pub-id pub-id-type="pmid">15821089</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ieraci</surname><given-names>A.</given-names></name><name><surname>Mallei</surname><given-names>A.</given-names></name><name><surname>Popoli</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Social isolation stress induces anxious-depressive-Like behavior and alterations of neuroplasticity-related genes in adult male mice.</article-title>
<source/><italic>Neural Plast.</italic>
<volume>2016</volume>:<issue>6212983</issue>. <pub-id pub-id-type="doi">10.1155/2016/6212983</pub-id>
<pub-id pub-id-type="pmid">26881124</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ionescu</surname><given-names>D. F.</given-names></name><name><surname>Niciu</surname><given-names>M. J.</given-names></name><name><surname>Mathews</surname><given-names>D. C.</given-names></name><name><surname>Richards</surname><given-names>E. M.</given-names></name><name><surname>Zarate</surname><given-names>CA</given-names><suffix>Jr</suffix></name></person-group> (<year>2013</year>). <article-title>Neurobiology of anxious depression: a review.</article-title>
<source/><italic>Depress. Anxiety</italic>
<volume>30</volume>
<fpage>374</fpage>–<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1002/da.22095</pub-id>
<pub-id pub-id-type="pmid">23495126</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karkhanis</surname><given-names>A. N.</given-names></name><name><surname>Alexander</surname><given-names>N. J.</given-names></name><name><surname>Mccool</surname><given-names>B. A.</given-names></name><name><surname>Weiner</surname><given-names>J. L.</given-names></name><name><surname>Jones</surname><given-names>S. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Chronic social isolation during adolescence augments catecholamine response to acute ethanol in the basolateral amygdala.</article-title>
<source/><italic>Synapse</italic>
<volume>69</volume>
<fpage>385</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1002/syn.21826</pub-id>
<pub-id pub-id-type="pmid">25963724</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>W. B.</given-names></name><name><surname>Kim</surname><given-names>Y. B.</given-names></name><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Shen</surname><given-names>F. Y.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Chronic hyperosmotic stress converts GABAergic inhibition into excitation in vasopressin and oxytocin neurons in the rat.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>31</volume>
<fpage>13312</fpage>–<lpage>13322</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1440-11.2011</pub-id>
<pub-id pub-id-type="pmid">21917814</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. Y.</given-names></name><name><surname>Yang</surname><given-names>S. H.</given-names></name><name><surname>Kwon</surname><given-names>J.</given-names></name><name><surname>Lee</surname><given-names>H. W.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Mice subjected to uncontrollable electric shocks show depression-like behaviors irrespective of their state of helplessness.</article-title>
<source/><italic>Behav. Brain Res.</italic>
<volume>322</volume>
<fpage>138</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2017.01.008</pub-id>
<pub-id pub-id-type="pmid">28062258</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. B.</given-names></name><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Kim</surname><given-names>W. B.</given-names></name><name><surname>Shen</surname><given-names>F. Y.</given-names></name><name><surname>Lee</surname><given-names>S. W.</given-names></name><name><surname>Chung</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>GABAergic excitation of vasopressin neurons: possible mechanism underlying sodium-dependent hypertension.</article-title>
<source/><italic>Circ. Res.</italic>
<volume>113</volume>
<fpage>1296</fpage>–<lpage>1307</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301814</pub-id>
<pub-id pub-id-type="pmid">24103391</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>H. S.</given-names></name><name><surname>Charlet</surname><given-names>A.</given-names></name><name><surname>Hoffmann</surname><given-names>L. C.</given-names></name><name><surname>Eliava</surname><given-names>M.</given-names></name><name><surname>Khrulev</surname><given-names>S.</given-names></name><name><surname>Cetin</surname><given-names>A. H.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Evoked axonal oxytocin release in the central amygdala attenuates fear response.</article-title>
<source/><italic>Neuron</italic>
<volume>73</volume>
<fpage>553</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.11.030</pub-id>
<pub-id pub-id-type="pmid">22325206</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotwica</surname><given-names>G.</given-names></name><name><surname>Kaminska</surname><given-names>B.</given-names></name><name><surname>Franczak</surname><given-names>A.</given-names></name><name><surname>Kurowicka</surname><given-names>B.</given-names></name><name><surname>Staszkiewicz</surname><given-names>J.</given-names></name><name><surname>Skowronski</surname><given-names>M. T.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The effect of oxytocin on cortisol and corticosterone secretion in cyclic gilts–in vivo and in vitro studies.</article-title>
<source/><italic>Reprod. Biol.</italic>
<volume>4</volume>
<fpage>35</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="pmid">15094794</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwak</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Kaang</surname><given-names>B. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Social isolation selectively increases anxiety in mice without affecting depression-like behavior.</article-title>
<source/><italic>Korean J. Physiol. Pharmacol.</italic>
<volume>13</volume>
<fpage>357</fpage>–<lpage>360</lpage>. <pub-id pub-id-type="doi">10.4196/kjpp.2009.13.5.357</pub-id>
<pub-id pub-id-type="pmid">19915697</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>M.</given-names></name><name><surname>Misicka</surname><given-names>A.</given-names></name><name><surname>Olma</surname><given-names>A.</given-names></name><name><surname>Bankowski</surname><given-names>K.</given-names></name><name><surname>Stoev</surname><given-names>S.</given-names></name><name><surname>Chini</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.</article-title>
<source/><italic>J. Neuroendocrinol.</italic>
<volume>24</volume>
<fpage>609</fpage>–<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2012.02303.x</pub-id>
<pub-id pub-id-type="pmid">22375852</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A.</given-names></name><name><surname>Domes</surname><given-names>G.</given-names></name><name><surname>Kirsch</surname><given-names>P.</given-names></name><name><surname>Heinrichs</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine.</article-title>
<source/><italic>Nat. Rev. Neurosci.</italic>
<volume>12</volume>
<fpage>524</fpage>–<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3044</pub-id>
<pub-id pub-id-type="pmid">21852800</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mottolese</surname><given-names>R.</given-names></name><name><surname>Redoute</surname><given-names>J.</given-names></name><name><surname>Costes</surname><given-names>N.</given-names></name><name><surname>Le Bars</surname><given-names>D.</given-names></name><name><surname>Sirigu</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Switching brain serotonin with oxytocin.</article-title>
<source/><italic>Proc. Natl. Acad. Sci. U.S.A.</italic>
<volume>111</volume>
<fpage>8637</fpage>–<lpage>8642</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1319810111</pub-id>
<pub-id pub-id-type="pmid">24912179</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murai</surname><given-names>Y.</given-names></name><name><surname>Nakashima</surname><given-names>T.</given-names></name><name><surname>Miyata</surname><given-names>S.</given-names></name><name><surname>Kiyohara</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Different effect of oxytocin on membrane potential of supraoptic oxytocin neurons in virgin female and male rats in vitro.</article-title>
<source/><italic>Neurosci. Res.</italic>
<volume>30</volume>
<fpage>35</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-0102(97)00117-X</pub-id>
<pub-id pub-id-type="pmid">9572578</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>I. D.</given-names></name><name><surname>Slattery</surname><given-names>D. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Oxytocin in general anxiety and social fear: a translational approach.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>79</volume>
<fpage>213</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.06.004</pub-id>
<pub-id pub-id-type="pmid">26208744</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olff</surname><given-names>M.</given-names></name><name><surname>Frijling</surname><given-names>J. L.</given-names></name><name><surname>Kubzansky</surname><given-names>L. D.</given-names></name><name><surname>Bradley</surname><given-names>B.</given-names></name><name><surname>Ellenbogen</surname><given-names>M. A.</given-names></name><name><surname>Cardoso</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The role of oxytocin in social bonding, stress regulation and mental health: an update on the moderating effects of context and interindividual differences.</article-title>
<source/><italic>Psychoneuroendocrinology</italic>
<volume>38</volume>
<fpage>1883</fpage>–<lpage>1894</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.06.019</pub-id>
<pub-id pub-id-type="pmid">23856187</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G.</given-names></name><name><surname>Franklin</surname><given-names>K. B.</given-names></name></person-group> (<year>2004</year>). <source/><italic>The Mouse Brain in Stereotaxic Coordinates.</italic>
<publisher-loc>Houston, TX</publisher-loc>: <publisher-name>Gulf professional publishing</publisher-name>.</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pournajafi-Nazarloo</surname><given-names>H.</given-names></name><name><surname>Kenkel</surname><given-names>W.</given-names></name><name><surname>Mohsenpour</surname><given-names>S. R.</given-names></name><name><surname>Sanzenbacher</surname><given-names>L.</given-names></name><name><surname>Saadat</surname><given-names>H.</given-names></name><name><surname>Partoo</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Exposure to chronic isolation modulates receptors mRNAs for oxytocin and vasopressin in the hypothalamus and heart.</article-title>
<source/><italic>Peptides</italic>
<volume>43</volume>
<fpage>20</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.peptides.2013.02.007</pub-id>
<pub-id pub-id-type="pmid">23439320</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripamonti</surname><given-names>S.</given-names></name><name><surname>Ambrozkiewicz</surname><given-names>M. C.</given-names></name><name><surname>Guzzi</surname><given-names>F.</given-names></name><name><surname>Gravati</surname><given-names>M.</given-names></name><name><surname>Biella</surname><given-names>G.</given-names></name><name><surname>Bormuth</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons.</article-title>
<source/><italic>eLife</italic>
<volume>6</volume>:<issue>e22466</issue>. <pub-id pub-id-type="doi">10.7554/eLife.22466</pub-id>
<pub-id pub-id-type="pmid">28231043</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberson-Nay</surname><given-names>R.</given-names></name><name><surname>Mcclure</surname><given-names>E. B.</given-names></name><name><surname>Monk</surname><given-names>C. S.</given-names></name><name><surname>Nelson</surname><given-names>E. E.</given-names></name><name><surname>Guyer</surname><given-names>A. E.</given-names></name><name><surname>Fromm</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Increased amygdala activity during successful memory encoding in adolescent major depressive disorder: an FMRI study.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>60</volume>
<fpage>966</fpage>–<lpage>973</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.02.018</pub-id>
<pub-id pub-id-type="pmid">16603133</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>C.</given-names></name><name><surname>Jang</surname><given-names>D. C.</given-names></name><name><surname>Jung</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>Y. G.</given-names></name><name><surname>Shim</surname><given-names>H. G.</given-names></name><name><surname>Ryu</surname><given-names>H. H.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>STIM1 regulates somatic Ca<sup>2+</sup> signals and intrinsic firing properties of cerebellar purkinje neurons.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>37</volume>
<fpage>8876</fpage>–<lpage>8894</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3973-16.2017</pub-id><pub-id pub-id-type="pmid">28821659</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scantamburlo</surname><given-names>G.</given-names></name><name><surname>Ansseau</surname><given-names>M.</given-names></name><name><surname>Geenen</surname><given-names>V.</given-names></name><name><surname>Legros</surname><given-names>J. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Intranasal oxytocin as an adjunct to escitalopram in major depression.</article-title>
<source/><italic>J. Neuropsychiatry Clin. Neurosci.</italic>
<volume>23</volume>:<issue>E5</issue>. <pub-id pub-id-type="doi">10.1176/jnp.23.2.jnpe5</pub-id>
<pub-id pub-id-type="pmid">21677229</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheline</surname><given-names>Y. I.</given-names></name><name><surname>Barch</surname><given-names>D. M.</given-names></name><name><surname>Donnelly</surname><given-names>J. M.</given-names></name><name><surname>Ollinger</surname><given-names>J. M.</given-names></name><name><surname>Snyder</surname><given-names>A. Z.</given-names></name><name><surname>Mintun</surname><given-names>M. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study.</article-title>
<source/><italic>Biol. Psychiatry</italic>
<volume>50</volume>
<fpage>651</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(01)01263-X</pub-id>
<pub-id pub-id-type="pmid">11704071</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>L. M.</given-names></name><name><surname>Liberzon</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>The neurocircuitry of fear, stress, and anxiety disorders.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>35</volume>
<fpage>169</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.83</pub-id>
<pub-id pub-id-type="pmid">19625997</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>D. A.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2010a</year>). <article-title>Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>58</volume>
<fpage>56</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.06.038</pub-id>
<pub-id pub-id-type="pmid">19589349</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slattery</surname><given-names>D. A.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2010b</year>). <article-title>Oxytocin and major depressive disorder: experimental and clinical evidence for links to aetiology and possible treatment.</article-title>
<source/><italic>Pharmaceuticals</italic>
<volume>3</volume>
<fpage>702</fpage>–<lpage>724</lpage>. <pub-id pub-id-type="pmid">27713275</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takao</surname><given-names>K.</given-names></name><name><surname>Nagatani</surname><given-names>T.</given-names></name><name><surname>Kitamura</surname><given-names>Y.</given-names></name><name><surname>Kawasaki</surname><given-names>K.</given-names></name><name><surname>Hayakawa</surname><given-names>H.</given-names></name><name><surname>Yamawaki</surname><given-names>S.</given-names></name></person-group> (<year>1995</year>). <article-title>Chronic forced swim stress of rats increases frontal cortical 5-HT2 receptors and the wet-dog shakes they mediate, but not frontal cortical beta-adrenoceptors.</article-title>
<source/><italic>Eur. J. Pharmacol.</italic>
<volume>294</volume>
<fpage>721</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(95)00620-6</pub-id>
<pub-id pub-id-type="pmid">8750738</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Tao</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Oxytocin activation of neurons in ventral tegmental area and interfascicular nucleus of mouse midbrain.</article-title>
<source/><italic>Neuropharmacology</italic>
<volume>77</volume>
<fpage>277</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.10.004</pub-id>
<pub-id pub-id-type="pmid">24148809</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viviani</surname><given-names>D.</given-names></name><name><surname>Charlet</surname><given-names>A.</given-names></name><name><surname>Van Den Burg</surname><given-names>E.</given-names></name><name><surname>Robinet</surname><given-names>C.</given-names></name><name><surname>Hurni</surname><given-names>N.</given-names></name><name><surname>Abatis</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Oxytocin selectively gates fear responses through distinct outputs from the central amygdala.</article-title>
<source/><italic>Science</italic>
<volume>333</volume>
<fpage>104</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1126/science.1201043</pub-id>
<pub-id pub-id-type="pmid">21719680</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Social support moderates stress effects on depression.</article-title>
<source/><italic>Int. J. Ment. Health Syst.</italic>
<volume>8</volume>:<issue>41</issue>. <pub-id pub-id-type="doi">10.1186/1752-4458-8-41</pub-id>
<pub-id pub-id-type="pmid">25422673</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T. T.</given-names></name><name><surname>Simmons</surname><given-names>A. N.</given-names></name><name><surname>Matthews</surname><given-names>S. C.</given-names></name><name><surname>Tapert</surname><given-names>S. F.</given-names></name><name><surname>Frank</surname><given-names>G. K.</given-names></name><name><surname>Max</surname><given-names>J. E.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Adolescents with major depression demonstrate increased amygdala activation.</article-title>
<source/><italic>J. Am. Acad. Child Adolesc. Psychiatry</italic>
<volume>49</volume>
<fpage>42</fpage>–<lpage>51</lpage>.<pub-id pub-id-type="pmid">20215925</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatawara</surname><given-names>C. J.</given-names></name><name><surname>Einfeld</surname><given-names>S. L.</given-names></name><name><surname>Hickie</surname><given-names>I. B.</given-names></name><name><surname>Davenport</surname><given-names>T. A.</given-names></name><name><surname>Guastella</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial.</article-title>
<source/><italic>Mol. Psychiatry</italic>
<volume>21</volume>
<fpage>1225</fpage>–<lpage>1231</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.162</pub-id>
<pub-id pub-id-type="pmid">26503762</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>M.</given-names></name><name><surname>Takayanagi</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Kimura</surname><given-names>T.</given-names></name><name><surname>Young</surname><given-names>L. J.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice.</article-title>
<source/><italic>J. Neurosci.</italic>
<volume>29</volume>
<fpage>2259</fpage>–<lpage>2271</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5593-08.2009</pub-id>
<pub-id pub-id-type="pmid">19228979</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Xue</surname><given-names>Y.</given-names></name><name><surname>An</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>5-HT<sub>2C</sub>R antagonist/5-HT<sub>2C</sub>R inverse agonist recovered the increased isolation-induced aggressive behavior of BALB/c mice mediated by ADAR1 (p110) expression and Htr2c RNA editing.</article-title>
<source/><italic>Brain Behav.</italic>
<volume>8</volume>:<issue>e00929</issue>. <pub-id pub-id-type="doi">10.1002/brb3.929</pub-id>
<pub-id pub-id-type="pmid">29541541</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zingg</surname><given-names>H. H.</given-names></name><name><surname>Laporte</surname><given-names>S. A.</given-names></name></person-group> (<year>2003</year>). <article-title>The oxytocin receptor.</article-title>
<source/><italic>Trends Endocrinol. Metab.</italic>
<volume>14</volume>
<fpage>222</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1016/S1043-2760(03)00080-8</pub-id><pub-id pub-id-type="pmid">12826328</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoicas</surname><given-names>I.</given-names></name><name><surname>Slattery</surname><given-names>D. A.</given-names></name><name><surname>Neumann</surname><given-names>I. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Brain oxytocin in social fear conditioning and its extinction: involvement of the lateral septum.</article-title>
<source/><italic>Neuropsychopharmacology</italic>
<volume>39</volume>
<fpage>3027</fpage>–<lpage>3035</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.156</pub-id>
<pub-id pub-id-type="pmid">24964815</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>